1-3 of 3
Yan Zhuang Yap
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Utility of Circulating Tumor (ct)DNA Quantity and Kinetics in Patients Undergoing CAR T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma

Imogen Caldwell, Yan Zhuang Yap, Mark R Dowling, Javad Saghebi, Aaron Jun Ning Wong, Roxane Legaie, Rainier Arnolda, Clarissa Wilson, Danielle Ignacio, Nicole O'Leary, Stephanie Yaung, Bowdoin Su, Corinna Woestmann, Michael Dickinson, Ella Thompson, Piers Blombery
Journal: Blood
Blood (2023) 142 (Supplement 1): 7160.
https://doi.org/10.1182/blood-2023-182999
Published: 2023
Journal Articles

Favorable Outcomes of DDX41 -Mutated MDS and Low Blast Count AML Treated with Azacitidine with or without Lenalidomide (ALLG MDS4 Trial)

Ing S Tiong, William S Stevenson, Meaghan Wall, Yan Zhuang Yap, John F. Seymour, Melita Kenealy, Piers Blombery
Journal: Blood
Blood (2022) 140 (Supplement 1): 4090–4091.
https://doi.org/10.1182/blood-2022-162880
Published: 2022
Journal Articles

Utility of High-Throughput Sequencing of Immunoglobulin Genes for MRD in Lymphoid Malignancy in the Context of Current Immunotherapeutics

Imogen R Caldwell, Michael Ingbritsen, Yan Zhuang Yap, Mark R Dowling, Ing S Tiong, David A Westerman, Piers Blombery
Journal: Blood
Blood (2022) 140 (Supplement 1): 10731–10732.
https://doi.org/10.1182/blood-2022-162228
Published: 2022